Article
Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE.
The Journal of clinical investigation - 1 Aug 2007
Bradley Michelle N, Hong Cynthia, Chen Mingyi, Joseph Sean B, Wilpitz Damien C, Wang Xuping, Lusis Aldons J, Collins Allan, Hseuh Willa A, Collins Jon L, Tangirala Rajendra K, Tontonoz Peter
Abstract excerpt
Liver X receptors (LXRs) alpha and beta are transcriptional regulators of cholesterol homeostasis and potential targets for the development of antiatherosclerosis drugs. However, the specific roles of individual LXR isotypes in atherosclerosis and the pharmacological effects of synthetic agonists remain unclear. Previous work has shown that mice lacking LXRalpha accumulate cholesterol in the liver but not in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
